Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice

Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression

(2013) Chi-Yu Zhang et al.   BIOTECHNOLOGY LETTERS

Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression

(2013) Kuo Wang et al.   BMC CANCER

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells

(2013) Dong-Ze Qiu et al.   BMC Complementary and Alternative Medicine

PKB/Akt-Dependent Regulation of Cell Motility

(2013) G. Xue et al.   JNCI-Journal of the National Cancer Institute

APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway

(2013) Guihua Wang et al.   PLoS One

Huaier Aqueous Extract Inhibits Ovarian Cancer Cell Motility via the AKT/GSK3β/β-Catenin Pathway

(2013) Xiaohui Yan et al.   PLoS One

Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway

(2013) Hongzhong Li et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma

(2012) YuXiang Fang et al.   HEPATOLOGY

Dietary restriction suppresses tumor growth, reduces angiogenesis, and improves tumor microenvironment in human non-small-cell lung cancer xenografts

(2012) Bao-Quan Lin et al.   LUNG CANCER

Dehydrocostuslactone Suppresses Angiogenesis In Vitro and In Vivo through Inhibition of Akt/GSK-3β and mTOR Signaling Pathways

(2012) Chih-Ya Wang et al.   PLoS One

Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis

(2012) Dan Liu et al.   PLoS One

Apocrine-Eccrine Carcinomas: Molecular and Immunohistochemical Analyses

(2012) Long P. Le et al.   PLoS One

HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway

(2011) Kyung Hee Jung et al.   CANCER LETTERS

Metastasis and AKT activation

(2011) Meng Qiao et al.   CELL CYCLE

Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor

(2010) Fanghua Qi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial–mesenchymal transition

(2009) Liang Liu et al.   CANCER SCIENCE

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data

(2009) Shawn J. Pelletier et al.   LIVER TRANSPLANTATION

PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells

(2008) Dan Li et al.   ANTI-CANCER DRUGS

Molecular components of the adherens junction

(2008) Carien M. Niessen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice

(2008) Bi-Wei Yang et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy

(2008) Zhong Wang et al.   NATURE